These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23337178)

  • 1. Importance of meta-analysis of long-term trials of low-molecular-weight heparin vs vitamin K antagonist in pulmonary embolism.
    Koracevic GP
    Am J Emerg Med; 2013 Mar; 31(3):627-8. PubMed ID: 23337178
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention and treatment of venous thromboembolism in patients with cancer].
    Struve S; Wendtner CM
    Dtsch Med Wochenschr; 2012 Oct; 137(40):2007-9. PubMed ID: 22987155
    [No Abstract]   [Full Text] [Related]  

  • 3. [Conventional or low molecular weight heparin in the treatment of venous thromboembolic disease?].
    Ruiz Manzano J; Monreal M
    Med Clin (Barc); 1998 Nov; 111(18):697-9. PubMed ID: 9887434
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hematochezia during anticoagulation. Pulmonary embolism as a life saver?].
    Stiefelhagen P
    MMW Fortschr Med; 2013 Dec; 155(21-22):30. PubMed ID: 24724260
    [No Abstract]   [Full Text] [Related]  

  • 5. [Internist patients are strongly thrombosis endangered. CERTIFY study has arrived].
    MMW Fortschr Med; 2007 May; 149(20):52-3. PubMed ID: 18051966
    [No Abstract]   [Full Text] [Related]  

  • 6. Should vitamin K antagonist therapy be started simultaneously with parenteral anticoagulation: a meta-analysis?
    Qayyum F; Holbrook A; Lam J; Kovacs MJ; Schulman S
    Blood Coagul Fibrinolysis; 2012 Dec; 23(8):705-13. PubMed ID: 23080362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute pulmonary embolism.
    Agnelli G; Becattini C
    N Engl J Med; 2010 Jul; 363(3):266-74. PubMed ID: 20592294
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cancer, thromboembolia and antithrombotic therapy: is there an anticoagulant of choice?].
    Scharf RE
    Dtsch Med Wochenschr; 2011 Nov; 136(47):2403. PubMed ID: 22094968
    [No Abstract]   [Full Text] [Related]  

  • 9. Pulmonary embolism in patients over 90 years of age.
    Monreal M; López-Jiménez L
    Curr Opin Pulm Med; 2010 Sep; 16(5):432-6. PubMed ID: 20671514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The treatment of deep venous thrombosis with low-molecular-weight heparin].
    Samama MM; Achkar A; Horellou MH
    Rev Med Brux; 1995; 16(4):304-9. PubMed ID: 7481248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term management of patients after venous thromboembolism.
    Kearon C
    Circulation; 2004 Aug; 110(9 Suppl 1):I10-8. PubMed ID: 15339876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Low-molecular-weight heparin in deep venous thrombosis. Dosage for all weight classes].
    MMW Fortschr Med; 2003 Jun; 145(24):56. PubMed ID: 12866309
    [No Abstract]   [Full Text] [Related]  

  • 13. Is there enough evidence that low-molecular-weight heparin is superior to unfractionated heparin in pulmonary embolism?
    Sharma GK
    Arch Intern Med; 2000 Jul; 160(13):2065-6. PubMed ID: 10888989
    [No Abstract]   [Full Text] [Related]  

  • 14. [Deep venous thrombosis and pulmonary embolism].
    Humbert M; Parent F; Simonneau G
    Rev Prat; 2002 Mar; 52(5):555-64. PubMed ID: 11949510
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of venous thromboembolism: unfractionated heparin or low molecular weight heparins?
    Agnelli G
    Haematologica; 1995; 80(2 Suppl):78-83. PubMed ID: 7628776
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic approaches to acute pulmonary embolism].
    Grosser KD
    Internist (Berl); 2005 Jan; 46(1):97-8. PubMed ID: 15791701
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of palliative low-molecular-weight heparin for treating venous thromboembolism in patients with advanced cancer.
    Tran QN
    Am J Hosp Palliat Care; 2010 Sep; 27(6):416-9. PubMed ID: 20197558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The optimal duration of anticoagulant treatment following pulmonary embolism].
    Couturaud F
    Rev Mal Respir; 2011 Dec; 28(10):1265-77. PubMed ID: 22152935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter to the editor regarding cochrane reviews.
    Cundiff DK
    MedGenMed; 2001 Aug; 3(4):11. PubMed ID: 11549990
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anticoagulants in prevention and treatment of pulmonary thromboembolic diseases].
    Gherasim L
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1976; 28(5):335-41. PubMed ID: 14369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.